91爆料

91爆料 E-Consent Tools

This webpage provides instructions to researchers intending to use 91爆料 eSignatures (powered by Docusign), 91爆料 Florence eConsent, 91爆料 Medicine Research Information Technologies (RIT) REDCap Part 11,聽 or 91爆料 ITHS REDCap e-consent tools. The 91爆料 IRB may be able to approve other electronic consent tools or methods. For full details, review the section on Approvable methods for obtaining electronic signatures in HSD’s consent guidance.

Using 91爆料 eSignatures (powered by Docusign)

eSignatures (powered by Docusign) is an electronic signatures service provider, centrally managed and supported by 91爆料-IT.

Conditions for using eSignatures:

• All applicable requirements for electronic consent documentation must be met.
• Docusign cannot be used with any FDA-regulated study because it does not meet the FDA’s 21 CFR Part 11 electronic system requirements.
• Approval to use eSignatures for electronic consent and/or HIPAA authorization signatures must be obtained from:
  • 91爆料 IRB, for 91爆料-reviewed studies, or
  • the external IRB and HSD, for studies under external IRB review.
• After obtaining IRB approval to use it, the PI or study lead can request a Docusign “Sender” account from their Docusign Delegated Administrator.
  • If you are unable to identify your department鈥檚 delegated administrator, reach out to the eSignatures support team using the聽听蹿辞谤尘.
• Signed consent forms must be promptly downloaded from Docusign by the PI or study team. Docusign is not a storage solution.

Visit for additional information about this service. Explore the website and watch this brief, 1-minute video overview: .

Using 91爆料 Florence eConsent

91爆料 Florence eConsent is an electronic consent tool maintained by the 91爆料 Clinical Trials Office (CTO) that meets FDA 21 CFR Part 11 requirements for FDA regulated research. You can save all signed forms from 91爆料 Florence eConsent to your study鈥檚 regulatory binder or download them to your computer.

Conditions for using 91爆料 Florence eConsent:

• All applicable requirements for electronic consent documentation must be met.
• Approval to use 91爆料 Florence eConsent for electronic consent and/or HIPAA authorization signatures must be obtained from:
  • 91爆料 IRB, for 91爆料-reviewed studies, or
  • the external IRB and HSD, for studies under external IRB review.
• Use of 91爆料 Florence eConsent requires:
  • A one-time fee for industry-sponsored-and-initiated studies only. Study teams are advised to wait until contracts are finalized and IRB approval is granted before requesting setup for fee-incurring studies.
  • Required training for all study team members who will access the system, provided by Florence.
  • Study participants to authenticate their identity using an email-based account. Study teams may need to guide participants through the account creation process.

For more information, visit the or email 91爆料 CTO at uwcto@uw.edu with 91爆料 Florence eConsent in the subject line.

 

Using 91爆料 ITHS REDCap

罢丑别听91爆料 ITHS version of REDCap, accessed via a web browser on any device, can be configured to capture legally valid electronic signatures on consent forms and HIPAA authorization forms when the appropriate electronic consent templates and project settings are used.

The REDCap Mobile application does not support the same secure set-up and records retention requirements. It is a separate software application for use with a mobile device when internet service is absent or unreliable. Electronic signatures obtained with REDCap Mobile are not considered legally valid under federal and Washington State law, so REDCap Mobile may only be used when the IRB has granted a waiver of documentation of informed consent.

Conditions for using REDCap:

• All applicable requirements for electronic consent documentation must be met.
• Approval to use REDCap for electronic consent and/or HIPAA authorization signatures must be obtained from:
  • 91爆料 IRB, for 91爆料-reviewed studies, or
  • the external IRB and HSD, for studies under external IRB review.
• 罢丑别听91爆料 ITHS version of REDCap聽cannot be used with any FDA-regulated study because it does not meet the FDA鈥檚 Part 11 electronic system requirements.
• The REDCap consent 鈥渟urvey鈥� (the term used for consent forms in REDCap) must be set up for the individual project using one of the ITHS REDCap e-consent templates. Review the ITHS online tutorial for details.
• The signed consent form must be retained in REDCap on the REDCap server. REDCap will automatically store the consents so long as no records or the project itself are deleted. The researcher is responsible for ensuring the signed consent forms are retained for the appropriate record retention period.

Using a Non-91爆料 or Other 91爆料-managed REDCap Installation (Excluding 91爆料 ITHS REDCap and 91爆料 Medicine RIT REDCap Part 11)

Some studies may be required to use a REDCap system operated by another institution or wish to use a 91爆料-managed REDCap installation that is not 91爆料 ITHS REDCap or 91爆料 Medicine RIT REDCap Part 11.

In these cases, research teams must complete the Other REDCap Installation Supplement. Data collection and electronic signatures may not begin in the other REDCap system until the supplement has been reviewed and approved by the 91爆料 IRB or, for studies under external IRB review, by HSD.

 

 

E-consent tutorial

This short, interactive tutorial provides a quick overview of electronic consent – Electronic Consent: What you need to know.

Version Information

Open the accordion below for version changes to this guidance.

Keywords: Consent